THE CRITICAL ANALYSIS OF NOVARTIS V CIPLA CASE VERDICT BY SUPREME COURT.
The Critical Analysis of Novartis V Cipla Case Verdict by Supreme Court. In a landmark judgment that has the potential to change the direction of India’s pharmaceutical business, The Supreme Court denied that the drug Glivec manufactured by the pharma giant Novartis is qualified for getting patent in India. A Brief about the Facts in Issue […]